Loading company…
Riskpilot
← Back to search
Sign in
Get full access
EPICURUS AS
AS
Active
Org 923932313
Villvinveien 18C, 3406 Tranby
General medical practice activities · NACE 8621
Est. 2019
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 567
-82% vs 2023
EBITDA margin
985.2%
+115% vs 2023
Equity ratio
-132.6%
Financial strength
Net profit 2024
NOK 82K
-65% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
-1M
2020
0M
+100%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 567
-82%
EBITDA
NOK 6K
+115%
Net profit
NOK 82K
-65%
Total assets
NOK 118K
-6%
Equity
NOK -156K
+35%
Employees
0
—
Company information
Legal name
EPICURUS AS
Org number
923932313
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. november 2019
Share capital
NOK 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Undervisning og medisinsk konsultasjon.
Contact
Address
Villvinveien 18C, 3406 Tranby
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Lier
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
-1M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
625
97
3
3
1
Staff expenses
−380
41
−0
−0
−0
EBITDA
−662
59
−51
−37
6
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−662
59
−51
−37
6
Net financials
−0
−1
−0
146
100
Profit before tax
−662
59
−51
110
106
Tax
−0
−0
−0
−124
23
Net profit
−662
59
−51
233
82
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
61
9
0
125
118
Equity
−480
−421
−472
−238
−156
Long-term debt
0
0
0
0
50
Short-term debt
541
430
472
363
224
Total debt
541
430
472
363
274
Financial ratios
5-year trend
EBITDA margin
985.2%
This company
15.8%
Market median
+6135% vs market
2020
2024
Equity ratio
-132.6%
This company
38.2%
Market median
-447% vs market
2020
2024
Return on equity
8235700.0%
This company
18.4%
Market median
+44759139% vs market
2020
2024
Net profit margin
14525.0%
This company
8.1%
Market median
+179221% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.75×
This company
0.62×
Market median
-182% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JS
Jørn Stian Lauritzsen
Chairman
2019
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Lauritzsen Holding As
Company
43.6%
43.6%
2022
Barske Gleder As
Company
24.3%
24.3%
2022
E&K Holding As
Company
20.7%
20.7%
2022
Anders Heim
Individual
7.5%
7.5%
2022
Kopperud Mikalsen Invest As
Company
3.9%
3.9%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of EPICURUS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Jørn Stian Lauritzsen
Chairman
0 companies